drugset / Trial / NCT00009178

Treatment of Bulimia Nervosa in a Primary Care Setting

NCT00009178

RandomizedParallel-groupDouble-blindTreatment

Summary

Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this disorder cannot be treated effectively in a primary care setting. This assumption has never been tested empirically, and is probably incorrect. In the last 15 years, effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers. The broad aim of this proposal is to examine whether these treatments, suitably adapted, can be usefully transferred to general health care settings. Specifically, the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting. The two major interventions are treatment with an antidepressant medication, fluoxetine, and with a form of cognitive behavioral therapy, guided self-help, designed for use in primary care.

Timeline

Start
1998-03
Primary completion
Completion
2001-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule

Indications